Published: September 2024

Last updated: September 2024

How Can Health Technology Assessment Support Healthcare Sustainability: A Parallel Evaluation of Single-Use Versus Reusable Technology

INTRODUCTION
Single use medical devices’ environmental impact is known to generate sizable carbon emissions over a life cycle compared to a reusable equivalent. The SHTG have recognised the need to evaluate this health technology carbon hotspot as part of the HTA. Specifically, this environmental assessment was appropriate for parallel evaluation alongside a health economic analysis to support the decision-making process.

METHODS
Through the application of HTA and environmental management principles and reporting, the Greenhouse Gas (GHG) Protocols, ISO14040 and Publicly Available Specification 2050, a carbon footprint of single use rhinolaryngoscopes was compared with a reusable equivalent. Process activity data, real world data and secondary data were used to quantify carbon intensity. Data were extrapolated to estimate national GHG emissions and waste volumes. The technologies were categorized using thresholds based on the functional unit, to strengthen support for the HTA decision making process. Sensitivity analyses were performed. Further recommendations were made to promote the use of more sustainable health technologies.

RESULTS
The carbon emissions of a single use flexible rhinolaryngoscope compared to its reusable equivalent was 6.03kgCO2e and 3.26kgCO2e respectively. Data extrapolation (2264 procedures per annum) reveals the annual environmental impact of this technology, throughout NHS Scotland, to be 13,652kgCO2e and 7,381kgCO2e, for the single use and reusable devices, respectively. Raw material acquisition, the use of personal protective equipment and transportation were health technology carbon hotspots. The estimated waste volumes are 12.58 tonnes and negligible volumes of clinical waste per annum for the single use versus reusable equivalent, respectively. This pilot study recommends the use a reusable equivalent in this setting.

CONCLUSIONS
Aligned with NHS net zero targets, these findings confirm the need to perform a parallel environmental assessment of technologies alongside a HTA. LCA is a useful framework to comprehensively assess environmental impact of health technology. Data constraints can be overcome through the use of hybrid methodologies, aligned with HTA principles including transparency and reproducibility to enable sustainable HTA decision making.

You may also be interested in

Peer-reviewed publication

A Disease Progression Model Comparing the Long-Term Mobility and Respiratory Outcomes of Adults with Late-Onset Pompe Disease Receiving Cipaglucosidase Alfa Plus Miglustat versus Alglucosidase Alfa

YHEC authors: Amy Dymond, Will Green
Publication date: July 2026
Journal: Journal of Comparative Effectiveness Research

Abstract

AIM: Late-onset Pompe disease (LOPD) is a rare lysosomal disease primarily impacting muscle strength andrespiratory function. LOPD has a substantial burden despite the availability of alglucosidase alfa (alg). Patients often...

Peer-reviewed publication

Addressing Real-World Data Gaps: Estimating the UK Population Cost of Crohn’s Disease and Ulcerative Colitis Using A Flexible Cost-of-Illness Model Informed by the Optimal Patient Journey and IBDUK Patient Survey 2023

YHEC authors: Rachael MacDonald, Nick Hex, Barbara Uzdzinska, Jessica Pocock
Publication date: July 2026
Journal: BMC Health Services Research

Abstract

BACKGROUND: Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions affecting around 500,000 people in the UK and carries rising prevalence and substantial economic...

Peer-reviewed publication

Next Generation Methods in Health Technology Assessment (HTA): Need, Rigor, and Implementability

YHEC authors: Melissa Pegg
Publication date: July 2026
Journal: International Journal of Technology Assessment in Healthcare

Abstract

The Health Technology Assessment International (HTAi) 2025 annual meeting featured three main plenaries to explore next generation (NextGen) evidence in health technology assessment (HTA). In this commentary we capture the...